NEK2 and breast cancer: Future research and clinical trials are crucial in determining the safety, efficacy, and suitability of NEK2 as a clinical therapy target or in combination with the standard of care for TNBC, offering new hope for patients facing limited treatment options in this aggressive breast cancer subtype.